MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in FATE — Fate Therapeutics Inc

CIK 1705339 CAUSEWAY BAY, K3

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$64,342

+$13,017 QoQ

Shares Held

53,619

+2.4% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,178,526 across 240 Biotechnology names. FATE ranks #218 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	171,925	$76,771,388
2	REGN	Regeneron Pharmaceuticals, Inc.	69,854	$53,971,993
3	ALNY	Alnylam Pharmaceuticals, Inc.	81,325	$26,908,001
4	INSM	INSMED Inc	122,958	$20,106,091
5	RPRX	Royalty Pharma plc	419,129	$20,105,617
6	PRAX	Praxis Precision Medicines, Inc.	27,744	$8,938,838
7	ARWR	Arrowhead Pharmaceuticals, Inc.	139,598	$8,752,793
8	MRNA	Moderna, Inc.	147,589	$7,497,520

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$64,342	53,619	+2.4%	Shares	Defined	2026-05-15
2025-12-31	$51,325	52,373	+3.4%	Shares	Defined	2026-02-17
2025-09-30	$63,846	50,672	-11.6%	Shares	Defined	2025-11-14
2025-06-30	$64,199	57,321	-4.2%	Shares	Defined	2025-08-14
2025-03-31	$47,290	59,861	+4.5%	Shares	Defined	2025-05-15
2024-12-31	$94,513	57,281	-9.5%	Shares	Defined	2025-02-14
2024-09-30	$221,424	63,264	+22.3%	Shares	Defined	2024-11-14
2024-06-30	$169,719	51,744	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.